Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia

Trial ID or NCT#



not recruiting iconNOT RECRUITING


This clinical trial is looking at brain function in young patients receiving methotrexate for acute lymphoblastic leukemia. Learning about the long-term effects of methotrexate on brain function may help doctors plan cancer treatment.

Official Title

A Study of Neurocognitive Function in Children Treated for ALL

Eligibility Criteria

Ages Eligible for Study: 1 Year to 17 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Sheri Spunt
Paul Graham Fisher, MD
Paul Graham Fisher, MD
Neuro-oncologist, Pediatric neurologist
Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health
Neyssa Marina

Contact us to find out if this trial is right for you.


Pediatric Hematology/Oncology